Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Clinical Trials, Biological therapies, Epidemiology, Workforce, CML, Diversity, Equity, Inclusion, and Accessibility (DEI/DEIA) , Chronic Myeloid Malignancies, Diseases, Therapies, Myeloid Malignancies, Biological Processes
Type: Oral
Hematology Disease Topics & Pathways:
Clinical Trials, Biological therapies, Epidemiology, Workforce, CML, Diversity, Equity, Inclusion, and Accessibility (DEI/DEIA) , Chronic Myeloid Malignancies, Diseases, Therapies, Myeloid Malignancies, Biological Processes
Saturday, December 11, 2021: 4:00 PM-5:30 PM
B304-B305, Level 3, Building B
(Georgia World Congress Center)
Moderators:
Michael J. Mauro, MD, Memorial Sloan Kettering Cancer Center
and
Susan Branford, PhD, SA Pathology
Disclosures:
Mauro: Novartis: Consultancy, Research Funding; Takeda: Consultancy; Bristol Myers Squibb: Consultancy, Research Funding; Pfizer: Consultancy; Sun Pharma / SPARC: Research Funding. Branford: Novartis: Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding, Speakers Bureau; Cepheid: Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding; Qiagen: Honoraria, Membership on an entity's Board of Directors or advisory committees.
Chronic Myeloid Leukemia: Clinical and Epidemiological: Mechanisms of resistance and expanded therapies
4:00 PM
4:15 PM
4:30 PM
4:45 PM
5:00 PM
5:15 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH